HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ghislain Opdenakker Selected Research
Ghislain Opdenakker Research Topics
Disease
70
Inflammation (Inflammations)
04/2022 - 01/2002
36
Neoplasms (Cancer)
08/2020 - 07/2002
32
Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 08/2006
20
Epiretinal Membrane (Epiretinal Membranes)
01/2022 - 02/2007
19
Infections
01/2021 - 11/2003
16
Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2003
14
Malaria
01/2020 - 05/2010
13
Uveitis
04/2022 - 09/2004
13
Multiple Sclerosis
01/2020 - 01/2003
11
Neoplasm Metastasis (Metastasis)
11/2016 - 07/2002
10
Necrosis
02/2020 - 12/2004
8
Fibrosis (Cirrhosis)
01/2022 - 12/2012
7
Hypoxia (Hypoxemia)
01/2022 - 02/2015
7
Rheumatoid Arthritis
01/2021 - 03/2002
7
Septic Shock (Toxic Shock Syndrome)
10/2017 - 08/2002
6
Cerebral Malaria
11/2019 - 09/2006
6
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2018 - 06/2003
6
Peritonitis
09/2009 - 01/2006
5
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 10/2010
5
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2019 - 02/2010
5
Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
03/2018 - 05/2010
5
Pancreatic Neoplasms (Pancreatic Cancer)
10/2017 - 01/2016
5
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2017 - 02/2014
5
Shock
01/2014 - 08/2002
5
Pancreatitis
04/2009 - 01/2003
4
Sarcoidosis (Schaumann Disease)
04/2020 - 01/2016
4
Adenocarcinoma
12/2016 - 07/2010
4
Virus Diseases (Viral Diseases)
02/2016 - 06/2003
4
Sepsis (Septicemia)
03/2015 - 08/2002
4
Melanoma (Melanoma, Malignant)
11/2014 - 09/2006
3
COVID-19
11/2022 - 11/2020
3
Arthritis (Polyarthritis)
01/2021 - 01/2006
3
Ulcerative Colitis
02/2020 - 07/2014
3
Colitis
01/2018 - 11/2016
3
Crohn Disease (Crohn's Disease)
11/2016 - 11/2005
3
Chronic Pancreatitis
01/2016 - 05/2003
3
Breast Neoplasms (Breast Cancer)
11/2014 - 01/2005
Drug/Important Bio-Agent (IBA)
68
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
01/2021 - 01/2002
57
Matrix Metalloproteinases (MMPs)
IBA
01/2021 - 03/2002
41
Chemokines
IBA
11/2022 - 07/2002
31
Enzymes
IBA
01/2020 - 03/2002
30
Proteins (Proteins, Gene)
FDA Link
01/2022 - 07/2002
24
Cytokines
IBA
11/2022 - 05/2004
24
Peptide Hydrolases (Proteases)
FDA Link
01/2021 - 03/2002
17
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2021 - 07/2010
17
Immunosorbents
IBA
01/2020 - 09/2004
16
Biomarkers (Surrogate Marker)
IBA
01/2021 - 01/2013
12
Metalloproteases (Metalloproteinases)
IBA
08/2020 - 09/2006
10
Matrix Metalloproteinase Inhibitors
IBA
07/2019 - 06/2003
10
Ligands
IBA
01/2018 - 11/2003
9
Pharmaceutical Preparations
IBA
01/2019 - 10/2006
9
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2018 - 01/2006
7
Chemotactic Factors
IBA
11/2022 - 05/2004
7
Autoantigens
IBA
01/2022 - 01/2003
7
Autoantibodies
IBA
01/2022 - 12/2004
7
Retinaldehyde (Retinal)
IBA
01/2022 - 02/2015
7
CXC Chemokines
IBA
11/2014 - 01/2004
7
Interleukin-8 (Interleukin 8)
IBA
02/2014 - 01/2003
6
Peptides (Polypeptides)
IBA
01/2022 - 01/2014
6
Interferons
IBA
01/2021 - 06/2003
6
oxyamylose (COAM)
IBA
01/2014 - 10/2008
6
Zymosan
IBA
09/2009 - 01/2006
5
Complement System Proteins (Complement)
IBA
01/2021 - 09/2006
5
Gelatin
IBA
01/2021 - 02/2014
5
Tissue Inhibitor of Metalloproteinase-1
IBA
01/2020 - 01/2013
5
Biological Products
IBA
02/2018 - 07/2009
5
hemozoin
IBA
01/2014 - 08/2011
4
Interleukin-17 (Interleukin 17)
IBA
11/2022 - 12/2007
4
Gelatinases
IBA
01/2021 - 09/2004
4
cobaltous chloride (cobalt(II)chloride)
IBA
01/2021 - 12/2016
4
Streptozocin (Streptozotocin)
FDA Link
01/2021 - 01/2003
4
Antiviral Agents (Antivirals)
IBA
01/2021 - 10/2008
4
Epitopes
IBA
01/2021 - 03/2002
4
Infliximab (Remicade)
FDA Link
02/2020 - 11/2005
4
Insulin (Novolin)
FDA Link
10/2018 - 01/2003
4
progelatinase
IBA
08/2014 - 12/2004
4
Toll-Like Receptors (Toll-Like Receptor)
IBA
07/2010 - 11/2003
3
Protease Inhibitors (Protease Inhibitor)
IBA
11/2022 - 02/2016
3
Anti-Bacterial Agents (Antibiotics)
IBA
11/2022 - 09/2011
3
Adrenal Cortex Hormones (Corticosteroids)
IBA
04/2022 - 11/2019
3
Monoclonal Antibodies
IBA
04/2022 - 01/2014
3
Glycosaminoglycans
IBA
01/2022 - 08/2012
3
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2021 - 02/2014
3
Antigens
IBA
01/2021 - 01/2019
3
Glucose (Dextrose)
FDA Link
Generic
01/2021 - 12/2016
3
Dexamethasone (Maxidex)
FDA Link
Generic
11/2019 - 05/2010
3
Glucocorticoids
IBA
11/2019 - 01/2016
3
Interleukins
IBA
08/2019 - 07/2010
3
Interleukin-10 (Interleukin 10)
IBA
08/2019 - 05/2011
3
Prodrugs
IBA
01/2019 - 05/2013
3
pro-matrix metalloproteinase 9
IBA
01/2019 - 08/2011
3
Leukocyte Elastase (Neutrophil Elastase)
IBA
01/2019 - 03/2009
3
Interleukin-6 (Interleukin 6)
IBA
06/2018 - 01/2016
3
Endopeptidases
IBA
01/2018 - 10/2007
3
Zinc
IBA
01/2018 - 10/2007
3
Dextrans (Dextran)
FDA Link
01/2018 - 11/2016
3
Protein Isoforms (Isoforms)
IBA
12/2017 - 07/2002
3
Minocycline (Cyclops)
FDA Link
Generic
01/2017 - 06/2003
3
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
11/2016 - 03/2004
Therapy/Procedure
18
Therapeutics
04/2022 - 06/2003